IL4

Chr 5

interleukin 4

Also known as: BCGF-1, BCGF1, BSF-1, BSF1, IL-4

The protein encoded by this gene is a pleiotropic cytokine produced by activated T cells. This cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL13. This gene, IL13 and IL5 are found to be regulated coordinately by several long-range regulatory elements in an over 120 kilobase range on the chromosome. IL4 is considered an important cytokine for tissue repair, counterbalancing the effects of proinflammatory type 1 cytokines, however, it also promotes allergic airway inflammation. Moreover, IL-4, a type 2 cytokine, mediates and regulates a variety of human host responses such as allergic, anti-parasitic, wound healing, and acute inflammation. This cytokine has been reported to promote resolution of neutrophil-mediated acute lung injury. In an allergic response, IL-4 has an essential role in the production of allergen-specific immunoglobin (Ig) E. This pro-inflammatory cytokine has been observed to be increased in COVID-19 (Coronavirus disease 2019) patients, but is not necessarily associated with severe COVID-19 pathology. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]

OMIMResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

UniProtIschemic stroke
12
Active trials
299
Pubs (1 yr)
P/LP submissions
P/LP missense
1.52
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.52LOEUF
pLI 0.005
Z-score 0.70
OE 0.69 (0.341.52)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.35Z-score
OE missense 0.90 (0.751.08)
80 obs / 89.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.69 (0.341.52)
00.351.4
Missense OE?0.90 (0.751.08)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 4 / 5.8Missense obs/exp: 80 / 89.2Syn Z: -0.43

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

IL4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Congenital Heart Disease (CHD)

Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids

NOT YET RECRUITING
NCT06882772Phase PHASE1, PHASE2University of NebraskaStarted 2026-03
2 mL SunButyrate-TGPlacebo4 mL SunButyrate-TG
Ulcerative Colitis (UC)Crohn Disease (CD)

Wild Blueberries in Colitis

RECRUITING
NCT06698601Phase NAUniversität Duisburg-EssenStarted 2024-09-24
blueberry-rich dietControl diet
Crohn's Disease

Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease

RECRUITING
NCT06719778Phase NAUniversität Duisburg-EssenStarted 2024-08-01
Two-stage nutritional therapy concept
Metastatic Solid TumorAdvanced Cancer

High Definition Medicine for Solid Tumors Oncology

RECRUITING
NCT06590506Centro Nacional de Investigaciones Oncologicas CARLOS IIIStarted 2023-03-02
Wearable
Head and Neck Squamous Cell Carcinoma (HNSCC)HPV (Human Papillomavirus)-Associated CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

RECRUITING
NCT06797986Phase PHASE1, PHASE2Cellid Co., Ltd.Started 2026-02-04
BVAC-E6E7 (low level)BVAC-E6E7 (high level)BVAC-E6E7 (RP2D)
Migraine DisordersChronic MigraineEpisodic Migraine

Biochemical Profiling of Migraine Patients

RECRUITING
NCT06549270IRCCS National Neurological Institute "C. Mondino" FoundationStarted 2023-05-10
MAbs
Non-Allergic Rhinitis With Eosinophilia Syndrome

Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome

NOT YET RECRUITING
NCT07240376Phase NAHuazhong University of Science and TechnologyStarted 2025-11-25
Stapokibart (CM310)Placebo
ObesityDietary Inflammatory Index (DII)

Dietary Inflammatory Potential in Young Pleople With Obesity

NOT YET RECRUITING
NCT06971666Instituto Tecnológico y de Estudios Superiores de OccidenteStarted 2025-06-20
Hepatocellular CarcinomaHEPATITIS B CHRONICHepatitis B Chronic Infection

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

NOT YET RECRUITING
NCT07553767Phase EARLY_PHASE1Ningbo No.2 HospitalStarted 2026-03-31
Peginterferon alfa-2bTDFTAF
Parkinson DiseasePhysical InactivityPhysical Disability

Physical Activity on Neuroinflammation in Parkinson's Disease

RECRUITING
NCT06977204IRCCS National Neurological Institute "C. Mondino" FoundationStarted 2023-01-01
Asthma

Investigating Dupilumab's Effect in Asthma by Genotype

ACTIVE NOT RECRUITING
NCT03694158Phase PHASE4Boston Children's HospitalStarted 2021-09-08
DupilumabPlacebo
Healthy AdultsHigh AltitudeIsolation, Social

Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica

ENROLLING BY INVITATION
NCT06133530Phase NAIU University of Applied SciencesStarted 2023-09-24
Human milk oligosaccharidesMaltose